-transparent.png){kind=logo}
d-Fenfluramine (7.5 and 10 mg/kg i.p.) and quipazine (10 and 20 mg/kg i.p.) increased plasma prolactin levels in male rats. Metergoline (3 mg/kg p.o.) or p-chlorophenylalanine (100 mg/kg X 3, orally) pretreatment markedly blocked the prolactin-releasing effect of both d-fenfluramine and quipazine. This result suggests that the effect of these drugs on prolactin secretion could be mediated through a serotonergic mechanism. Brain serotonin may thus exert a stimulatory role on prolactin secretion in rats.
Related Publications
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
November 1996,
The American journal of psychiatry,
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
October 1976,
Psychopharmacology bulletin,
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
May 1992,
The British journal of psychiatry : the journal of mental science,
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
June 1983,
The Journal of pharmacology and experimental therapeutics,
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
February 1998,
The British journal of psychiatry : the journal of mental science,
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
May 1999,
Biological psychiatry,
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
August 1991,
The American journal of psychiatry,
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
March 1984,
Life sciences,
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
September 1997,
Biological psychiatry,
A Quattrone, and
G Di Renzo, and
G Schettini, and
G Tedeschi, and
F Scopacasa
March 1986,
European journal of pharmacology,
